CN Stock MarketDetailed Quotes

600566 Hubei Jumpcan Pharmaceutical

Watchlist
  • 30.36
  • +0.64+2.15%
Not Open Dec 10 15:00 CST
27.98BMarket Cap10.06P/E (TTM)

Hubei Jumpcan Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Jumpcan Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 10.179B--
--2024/FY-- / 9.358B--
--2023/FY9.655B / 10.055B--
--2022/FY8.996B / 8.582B--
--2021/FY7.631B / 7.233B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 10.179B--
--2024/FY-- / 9.358B--
--2023/FY9.655B / 10.055B--
--2022/FY8.996B / 8.582B--
--2021/FY7.631B / 7.233B--

Unlock Free Earnings Estimates

Hubei Jumpcan Pharmaceutical Earnings Reports

  • Hubei Jichuan Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Oct 26 00:00

  • Hubei Jumpcan Pharmaceutical Co., Ltd. 2024 Interim Report

    Aug 24 00:00

  • Summary of the semi-annual report of Hubei Jumpcan Pharmaceutical Co., Ltd. for 2024

    Aug 24 00:00

  • Hubei Jichuan Pharmaceutical Co., Ltd. Report for the first quarter of 2024

    Apr 20 00:00

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    SUNNY PERCISION
    831906
    28.92 +29.98%
    WUXINSUIZHUANG
    835174
    35.47 +29.97%
    MUPRO IFT.
    836422
    17.31 +29.95%
    HST
    870726
    29.60 +25.00%
    Jilin Joinature Polymer
    688716
    42.84 +20.00%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 10, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme The Concept of Three Children
    The Concept of Three Children
    Intraday+1.48%